Abdulrahman Alwaki
Papers
1
Total Citations
50
H-Index
1
About
Abdulrahman Alwaki is a leading figure in neuromodulation for drug-resistant epilepsy, with a focused expertise in centromedian thalamic deep brain stimulation (CM-DBS). His major contribution lies in clarifying the therapeutic potential of CM-DBS, particularly for generalized epilepsies like Lennox-Gastaut syndrome (LGS). In his landmark 2022 study, which has garnered 50 citations, Alwaki provided critical single-center evidence demonstrating that CM-DBS can be effective for patients who have exhausted other treatment options, offering a new avenue for seizure control where prior reports were inconclusive. This work has helped refine patient selection criteria and underscored the importance of targeting the centromedian nucleus in generalized epilepsy syndromes. Beyond this, Alwaki’s research continues to shape the field of functional neurosurgery, bridging the gap between experimental neuromodulation and clinical application. His findings have been instrumental in advancing personalized approaches to epilepsy surgery, making him a key contributor to the growing evidence base that supports DBS as a viable therapy for otherwise refractory cases.
Research Focus
Key Achievements
Top Papers
- 1